4//SEC Filing
Cahill Brian Joseph 4
Accession 0001415889-24-006003
CIK 0000827871other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 8:23 PM ET
Size
6.7 KB
Accession
0001415889-24-006003
Insider Transaction Report
Form 4
Cahill Brian Joseph
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-27+3,800→ 49,547 total - Tax Payment
Common Stock
2024-02-27$6.44/sh−1,589$10,233→ 47,958 total
Footnotes (2)
- [F1]Represents common stock issued upon satisfaction of certain performance criteria contained in performance stock units ("PSUs") granted in 2021.
- [F2]The disposition reported on this Form 4 represents shares withheld by the Issuer to cover the tax liability upon the vesting of the PSUs and does not represent a discretionary transaction by the Reporting Person.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeother
Related Parties
1- filerCIK 0001831591
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 8:23 PM ET
- Size
- 6.7 KB